We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

54 hedge funds and large institutions have $31.3M invested in Tempest Therapeutics in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

14% less funds holding

Funds holding: 63 → 54 (-9)

25% less capital invested

Capital invested by funds: $41.9M → $31.3M (-$10.6M)

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
54
Holders Change
-9
Holders Change %
-14.29%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
9
Reduced
16
Closed
23
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
Legal & General Group
Legal & General Group
United Kingdom
+$652K
2
ACA
Avoro Capital Advisors
New York
+$453K
3
BC
Broadfin Capital
New York
+$398K
4
Millennium Management
Millennium Management
New York
+$326K
5
ECM
Element Capital Management
New York
+$207K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.04M
2
GC
GMT Capital
Georgia
-$1.42M
3
State Street
State Street
Massachusetts
-$656K
4
Northern Trust
Northern Trust
Illinois
-$385K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$249K
Name Holding Trade Value Shares
Change 		Change in
Stake
TIM
51
Tortoise Investment Management
New York
$5K +$4.23K +1 New
UBS Group
52
UBS Group
Switzerland
$4K -$21.2K -5 -83%
Federated Hermes
53
Federated Hermes
Pennsylvania
$4K – – –
BWM
54
Baystate Wealth Management
Massachusetts
$2K – – –
TCOV
55
Trust Company of Vermont
Vermont
$2K – – –
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
$1K – – –
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
MAM
58
Meeder Asset Management
Ohio
$1K – – –
PAM
59
Panagora Asset Management
Massachusetts
$1K – – –
GC
60
GMT Capital
Georgia
– -$1.42M -259 Closed
Tudor Investment Corp
61
Tudor Investment Corp
Connecticut
– -$249K -45 Closed
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$187K -34 Closed
TCIM
63
TIAA CREF Investment Management
New York
– -$179K -33 Closed
TA
64
Teachers Advisors
New York
– -$127K -23 Closed
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
– -$121K -22 Closed
Charles Schwab
66
Charles Schwab
California
– -$107K -19 Closed
UBS AM
67
UBS AM
Illinois
– -$107K -19 Closed
AllianceBernstein
68
AllianceBernstein
Tennessee
– -$90K -16 Closed
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
– -$90K -16 Closed
Swiss National Bank
70
Swiss National Bank
Switzerland
– -$83K -15 Closed
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
– -$56K -10 Closed
SG Americas Securities
72
SG Americas Securities
New York
– -$55K -10 Closed
AIG
73
American International Group
New York
– -$36K -7 Closed
NFA
74
Nationwide Fund Advisors
Ohio
– -$38K -7 Closed
VOYA Investment Management
75
VOYA Investment Management
Georgia
– -$29K -5 Closed
1 2
3
4

TPST Hedge Fund Activity: Q2 2017 in Review

54 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2017, worth a combined $31.3M — down 25% from $41.9M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of TPST and 14 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Legal & General Group, adding an estimated $652K. The largest seller was BlackRock, cutting an estimated $2.04M.

  • 54 institutional investors held Tempest Therapeutics (TPST) as of Q2 2017, down from 63 in Q1 2017.
  • Funds reported $31.3M of Tempest Therapeutics stock for Q2 2017, down 25% quarter-over-quarter.
  • 14 funds opened new Tempest Therapeutics positions in Q2 2017 and 23 closed out, a net change of -9 holders.
  • The largest Tempest Therapeutics buyer in Q2 2017 was Legal & General Group, an estimated $652K added.
  • The largest Tempest Therapeutics seller in Q2 2017 was BlackRock, an estimated $2.04M sold.

Based on aggregated 13F filings for Q2 2017.